1[1]Gartshore G,Patterson J,Macrae IM.Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia[J].Exp Neurol,1997,147(2):353～360
3[3]Yamashita K,Kataoka Y,Sakurai Y,et al.Involvement of glial endothelin/nitric oxide in delayed neuronal death of rat hippocampus after transient forebrain ischemia[J].Cell Mol Neurrobiol,2000,20(5):541～551
4[4]Blann AD,Lip GY,Beevers DG,et al.Soluble P-selection in atherosclerosis:a comparison with endothelial cell and platelet markers.Thromb Haemost,1997,77(6):1077～1080
5[5]Cines DB,Pollak ES,Buck CA,et al.Endothelial cells in physiology and in the pathophysiology of vascelular disorders[J].Blood,1998,91:3527
6[6]Olah L,Misz M,Bereczki D,et al.Low doses of acetylsalicylic acid effectively inhibits thrombocyte aggregation after ischemic stroke[J].Orv Hetil,1996,137(9):455～459
7[7]Wu KK,Cartes J,Stinson V,et al.Platelet activation and early carotid atherosclerosis[J].Thromb Hatmost,1993,60:1544
8[8]Vestweber D,Blanks JE.Mechanisms that regulate the function of the selections and their ligands[J].Physiol Rev,1999,79(1):181～213
9[9]Schumacher H,Kaiser E,Schnabel PA,et al.Immunophenotypic characterisation of carotid plaque:increased amount of inflammatory cells as an independent predictor for ischemic symptoms[J].Eur J Vasc Endovasc surg,2001,21(6):494～501
10[10]Zunker P,Schick A,Padro T,et al.Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke:relation to stroke etiology[J].Clin Invest,1998,102(1):145～152
2BARRY S, COLLER E K, LESLEY E. S, et al. Evidenc1 That Glycocalicin Circulatesin Normal Plasma [ J 1 March,I 1984,794-799.
3ROBINSON M, MACHIN S, MACKIEI, et al. Comparison ofglycocalicin, thrombopoietin and reticulated platelet meas- urement as markers of platelet turner in HIV + samples [ J ]. platelet, 2001,12 : 108-113.
4KURATA Y, HAYASHI S;KIYOI T, et al. Diagnostic Value of Tests for Reticulated Platelets, Plasma Glycocalicin, and Thrombo-poietin Levels for Discriminating Between Hyper- destructive and Hypoplastic Thrombocytopenia[ J ]. Am J C1 in Path. 2001,115:656-664.
5DAVID G Y, GREGORY Y. H. L. ANDREW D B, et at. A reliable plasma marker of platelet activation, does it exist? [ J ]. American Journal of Hematology ,2002,70 : 139-144.
6PAUL C, GRAEME J lq, QILONG Y, et al. Endothelial and Platelet Activation in Acute Ischemic Stroke and Its Etiologi- cal Subtypes[ J]. Stroke ,2003,34:2132-2137.
